CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-15 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −1,450 | $15.25 | $22K | 1,397,447 |
| 2024-10-15 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $14.88 | $744K | 1,298,499 |
| 2024-10-08 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $13.83 | $691K | 1,346,494 |
| 2024-10-08 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $13.83 | $691K | 1,348,499 |
| 2024-10-08 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $13.83 | $691K | 1,346,494 |
| 2024-10-08 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $13.83 | $691K | 1,348,499 |
| 2024-09-18 | Karas Eric Chief Commercial Officer | Option exercise 10b5-1 | +10,000 | $1.50 | $15K | 15,693 |
| 2024-09-18 | Karas Eric Chief Commercial Officer | Sale 10b5-1 | −10,000 | $14.00 | $140K | 5,693 |
| 2024-09-18 | Karas Eric Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 594,588 | ||
| 2024-09-17 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $12.93 | $647K | 1,447,447 |
| 2024-09-17 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $12.93 | $647K | 1,398,499 |
| 2024-09-17 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $12.93 | $647K | 1,447,447 |
| 2024-09-17 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $12.93 | $647K | 1,398,499 |
| 2024-09-10 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $11.50 | $575K | 1,396,494 |
| 2024-09-10 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −50,000 | $11.50 | $575K | 1,448,499 |
| 2024-09-10 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $11.50 | $575K | 1,396,494 |
| 2024-09-10 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −50,000 | $11.50 | $575K | 1,448,499 |
| 2024-08-26 | Thompson Peter A. Director | Sale | −83,695 | $13.00 | $1.1M | 0 |
| 2024-08-26 | ORBIMED ADVISORS LLC Director | Sale | −83,695 | $13.00 | $1.1M | 0 |
| 2024-08-23 | Thompson Peter A. Director | Sale | −69,500 | $13.03 | $906K | 83,695 |
Page 11 of 14 · 267 trades